Literature DB >> 15308529

Increased matrix concentrations of IGFBP-5 in cancellous bone in osteoarthritis.

C A Sharp1, S J Brown, M W J Davie, P Magnusson, S Mohan.   

Abstract

BACKGROUND: In osteoarthritis cancellous bone adapts to meet altered mechanical loading. These changes may be mediated by insulin-like growth factors (IGF-I and IGF-II), but the matrix bound binding protein, IGFBP-5 has not been investigated.
OBJECTIVES: To measure IGF-I, IGF-II, and IGFBP-5 in femoral head bone from non-OA controls and patients with OA, and to relate these to apparent density (rhoA) and elastic modulus (Ec).
METHODS: rhoA, Ec, and IGF system components were measured in cancellous bone from superior and inferior regions of femoral heads from 31 patients with OA and 11 age selected controls.
RESULTS: Ec and rhoA were greater (p<0.05) in the superior region of all femoral heads. In primary OA, rhoA was increased in the inferior region (p<0.05). IGFBP-5 was increased, about twofold, at superior and inferior regions in primary OA (1.60 and 1.54 ng/mg bone, respectively, both p<0.05) and in Paget's disease (2.44 and 1.75 ng/mg bone, both p<0.05) compared with controls (0.73 and 0.95 ng/mg bone). In controls, inverse correlations between IGFBP-5 and both rhoA and Ec at superior (rs = -0.64 and -0.73, both p<0.05) and inferior regions (rs = -0.72, p<0.05 and -0.24 (NS)) were seen, but these were lost in OA.
CONCLUSIONS: IGFBP-5 may modulate cancellous bone formation by negative feedback. In end stage OA this is disrupted, but has little influence on material properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308529      PMCID: PMC1755128          DOI: 10.1136/ard.2003.013920

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  Differentiation of neural-crest-derived intermediate pluripotent progenitors into committed periodontal populations involves unique molecular signature changes, cohort shifts, and epigenetic modifications.

Authors:  Smit Jayant Dangaria; Yoshihiro Ito; Xianghong Luan; Thomas G H Diekwisch
Journal:  Stem Cells Dev       Date:  2010-09-06       Impact factor: 3.272

Review 2.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

3.  Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients.

Authors:  Le-Hoa Truong; Julia S Kuliwaba; Helen Tsangari; Nicola L Fazzalari
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

4.  Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Authors:  Yener N Yeni; X Neil Dong; Bingbing Zhang; Gary J Gibson; David P Fyhrie
Journal:  Clin Orthop Relat Res       Date:  2009-05-27       Impact factor: 4.176

5.  Identification of DNA methylation changes associated with disease progression in subchondral bone with site-matched cartilage in knee osteoarthritis.

Authors:  Yanfei Zhang; Naoshi Fukui; Mitsunori Yahata; Yozo Katsuragawa; Toshiyuki Tashiro; Shiro Ikegawa; Ming Ta Michael Lee
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

Review 6.  Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease.

Authors:  Cumming Duan; John B Allard
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.